Fleishman-Hillard's Role Advising Roche
"Fleishman-Hillard is counseling Roche, which now says it is doing everything possible to meet the demand for Tamiflu, according to Michael Rinaldo, head of F-H's health group in New York," O'Dwyer's PR Daily reports. "Roche says it is 'doing everything possible' to meet demand for flu drug." The company's reputation took a hit last month when it appeared to be "more eager to protect its 'monopoly' on its Tamiflu - the vaccine most effective in fighting bird flu - than preventing a worldwide avian flu pandemic," O'Dwyer's reported in November 2005. 
Other SourceWatch Resources
- Sabin Russell, "Biotech firm wants to regain control of avian flu drug: Gilead says deal with Roche Inc. threatens Tamiflu's production", San Francisco Chronicle, June 24, 2005.
- "F-H Guides Roche" O'Dwyer's PR Daily (sub req'd), November 8, 2005.
|This article is a stub. You can help by expanding it.|